Table 1.
Clinical and pathologic details of patients and specimens
| Characteristic | No. | Adequate (%) |
|---|---|---|
| Specimens | 248 | 225 (90.7) |
| MPE cell blocks | 124 | 114 (91.9) |
| Histology specimens | 124 | 111 (89.5) |
| Site | ||
| Lung | 75 | |
| Regional/distant lymph nodes | 29 | |
| Thorax/mediastinum | 16 | |
| Bone | 2 | |
| Subaxillary/abdominal mass | 2 | |
| Type | ||
| Surgical resection | 11 | 11 (100) |
| EBUS-TBNA | 8 | 8 (100) |
| Biopsy | 105 | 92 (87.6) |
| Endobronchial forceps biopsy | 38 | 30 (78.9) |
| CTG-CN | 31 | 30 (96.8) |
| Other histologic biopsy | 36 | 32 (88.9) |
| Patients | 124 | |
| Age (median) (y) | 29–85 (61) | |
| Sex | ||
| Male | 80 | |
| Female | 44 | |
| Diagnosis | ||
| Adenocarcinoma | 108 | |
| Squamous cell | 11 | |
| NSCLC, NOS | 5 | |
Abbreviations: MPE malignant pleural effusion, CTG-CN computed tomography-guided core needle biopsy, EBUS-TBNA endobronchial ultrasound-guided transbronchial needle aspiration biopsy, NSCLC, NOS non-small cell lung carcinoma, not otherwise specified